Trials / Completed
CompletedNCT02752893
Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- Dartmouth-Hitchcock Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators will establish a platform at Dartmouth-Hitchcock Medical Center to generate novel models of estrogen receptor alpha-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer, which will be used for research studies to develop novel treatment strategies and dissect signaling pathways underlying drug sensitivity and resistance.
Conditions
Timeline
- Start date
- 2017-01-30
- Primary completion
- 2019-04-03
- Completion
- 2019-04-03
- First posted
- 2016-04-27
- Last updated
- 2020-06-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02752893. Inclusion in this directory is not an endorsement.